Pharmaceuticals, Biotechnology and Life Sciences
• Company on track to submit European marketing application in Q4 2022 • No additional studies required PITTSBURGH, Sept. 21,…
SAN FRANCISCO and SAN DIEGO, Sept. 21, 2022 (GLOBE NEWSWIRE) — Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a clinical-stage precision…
WARRINGTON, Pa., Sept. 21, 2022 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple…
BOSTON, Sept. 21, 2022 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company focused on the discovery and…
SOUTH SAN FRANCISCO, Calif., Sept. 21, 2022 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO) a clinical-stage…
– Data presented at Pacific Spine Pain Society annual meeting – CLEVELAND, Sept. 21, 2022 (GLOBE NEWSWIRE) — SPR Therapeutics…
SANTA ANA, Calif., Sept. 21, 2022 (GLOBE NEWSWIRE) — NKGen Biotech, a biotechnology company harnessing the power of the body’s…
Guerbet announces U.S. Food and Drug Administration (FDA) approval of Elucirem™ (Gadopiclenol) FDA approval of EluciremTM (NDA 216986) was granted…
Clinical assessments three-months post-treatment report no serious adverse events and reduced seizure frequency to date in first trial participant Data…
2022 half-year results Slight business growth H1 revenue: €371.1 million, up 2.2% (-1.3% at CER1); sustained momentum in Asia and activity…